Working... Menu

Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01275248
Recruitment Status : Terminated (lack of efficacy)
First Posted : January 12, 2011
Last Update Posted : January 18, 2013
Information provided by (Responsible Party):
Transcept Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : September 2015
  Estimated Study Completion Date : September 2015